glp 1 drugs and depression The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy GLP-1 diabetes drugs could stop

L.KahnE

For patients with Long COVID and ME/CFS, achieving this specific brain state is profoundly therapeutic

Delving into its properties as a cognitive booster, there is evidence that DMAE increased choline and ACh extracellular levels in rats, thus improving spatial memory

PospisilikJAStaffordSGDemuthHUBrownseyRParkhouseWFinegoodDTet al

EllieVate Skin+ is a clinically formulated, prescription-grade serum that combines science-backed active ingredients with luxury-grade cosmetic components

A 2024 KFF study found Medicaid coverage could benefit 40% of adults and 26% of children with obesity, forcing policymakers to weigh cost, equity and long-term health outcomes as demand grows and new uses emerge